Novel Drug Delivery Systems Global Market Report 2025
상품코드:1810977
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
신규 약물전달 시스템 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년 연평균 성장률(CAGR)은 9.8%로, 1,710억 2,000만 달러로 성장합니다. 예측 기간 중 예상되는 성장은 전 세계적인 팬데믹 대응에 대한 관심 증가, 신속한 약물전달에 대한 수요 증가, 항균제 스튜어드십(antimicrobial drug stewardship)에 대한 인식 증가, 통제된 전달 방식을 지지하는 환경 및 포장 규제 강화, 의약품 의약품 혁신에 대한 민관 파트너십의 확대 등에 기인한다고 볼 수 있습니다. 이 기간 중 주요 동향으로는 나노 캐리어 및 나노에멀전의 채택, 생분해성 소재 및 자극 반응성 소재의 개발, 개별화 제형에 대한 3D 프린팅의 활용 확대, 경피 및 마이크로니들 기술의 발전, 제형 설계에 있으며, 인공지능의 채택 등을 들 수 있습니다.
신경질환 환자 증가는 신규 약물전달 시스템 시장의 성장을 가속할 것으로 예측됩니다. 뇌졸중과 같은 신경질환은 뇌로 가는 혈류가 차단되거나(허혈성 뇌졸중) 혈관이 파열(출혈성 뇌졸중)되어 발생하는 갑작스러운 신경 기능의 상실을 동반하며, 그 결과 뇌가 손상되어 인지, 감각, 운동 등에 장기적인 장애를 초래할 수 있습니다. 인구 고령화, 고혈압, 당뇨, 비만 등 생활습관병 증가, 만성 스트레스와 환경적 위험에 노출될 기회 증가 등의 요인이 신경장애 증가에 기여하고 있습니다. 새로운 약물전달 시스템은 혈액 뇌 장벽을 통과하는 약물의 표적화된 제어된 전달을 제공함으로써 이러한 장애를 치료하는 데 도움이 될 수 있습니다. 예를 들어 2024년 11월 영국 국민보건서비스(NHS)는 2023/24년 영국에서 뇌졸중 입원 환자 수가 11만 1,137명에 달했으며, 50-59세 연령대에서 가장 많이 증가하여 1만 2,533명이 새로 발병했다고 보고했습니다. 그 결과, 신경질환의 발병률 증가는 새로운 약물전달 시스템 시장에 박차를 가하고 있습니다.
새로운 약물전달 시스템 시장의 주요 기업은 환자의 순응도와 치료 효과를 향상시키기 위해 경구용 박막과 같은 제품으로 혁신을 일으키고 있습니다. 구강용 박막은 구강 내에 부착하는 속용성 스트립으로, 점막을 통해 약물을 혈류로 직접 전달합니다. 예를 들어 2024년 2월 미국의 제약 제제 회사인 CD Formulation사는 경구용 박막 기술을 발표했습니다. 이 기술은 소화관과 간 대사를 우회하여 약물의 빠른 흡수를 가능하게 하여 삼키기 어려운 환자에게 적합합니다. 또한 정확한 투약과 빠른 효과 발현을 가능하게 하여 여러 치료에서 치료의 정확성과 편의성을 향상시킵니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 신규 약물전달 시스템 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 신규 약물전달 시스템 시장 : 성장률 분석
세계의 신규 약물전달 시스템 시장 실적 : 규모와 성장, 2019-2024
세계의 신규 약물전달 시스템 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 신규 약물전달 시스템 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 신규 약물전달 시스템 시장 : 처방 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
리포솜
나노입자
마이크로스피어
하이드로겔
덴드리머
세계의 신규 약물전달 시스템 시장 : 신규 약물전달 시스템(NDDS)의 모드별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
표적 약물전달 시스템
제어 약물전달 시스템
조절형 약물전달 시스템
세계의 신규 약물전달 시스템 시장 : 루트별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구 약물전달 시스템
주사 약물전달 시스템
폐 약물전달 시스템
경피 약물전달 시스템
기타 루트
세계의 신규 약물전달 시스템 시장 : 치유 영역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
암
심혈관질환
신경질환
감염증
자가면역질환
세계의 신규 약물전달 시스템 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
전문 클리닉
연구 센터
기타 최종사용자
세계의 신규 약물전달 시스템 시장 : 서브 세분화, 리포솜(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
PEG화 리포솜
양이온성 리포솜
스텔스 리포솜
면역 리포솜
세계의 신규 약물전달 시스템 시장 : 서브 세분화, 나노입자(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
폴리머 나노입자
지질 나노입자
금속 나노입자
나노 결정
세계의 신규 약물전달 시스템 시장 : 서브 세분화, 마이크로스피어(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
생분해성 마이크로스피어
자성 마이크로스피어
방사성 마이크로스피어
점막 부착성 마이크로스피어
세계의 신규 약물전달 시스템 시장 : 서브 세분화, 하이드로겔(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
감열성 하이드로겔
pH 반응형 하이드로겔
주사 가능한 하이드로겔
스마트 하이드로겔
세계의 신규 약물전달 시스템 시장 : 서브 세분화, 덴드리머(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
PAMAM 덴드리머
PPI 덴드리머
페그화 덴드리머
하이브리드 덴드리머
제7장 지역별·국가별 분석
세계의 신규 약물전달 시스템 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 신규 약물전달 시스템 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
신규 약물전달 시스템 시장 : 경쟁 구도
신규 약물전달 시스템 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Bayer AG
Sanofi SA
Bristol-Myers Squibb Company
Thermo Fisher Scientific Company
AstraZeneca PLC
Abbott Laboratories
Novartis AG
GlaxoSmithKline PLC(GSK)
Takeda Pharmaceutical Company Limited
Eli Lilly and Company
Gilead Sciences
Amgen Inc.
Teva Pharmaceutical Industries Ltd.
Otsuka Pharmaceutical Co. Ltd.
Boston Scientific Corporation
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
신규 약물전달 시스템 시장 2029 : 새로운 기회를 제공하는 국가
신규 약물전달 시스템 시장 2029 : 새로운 기회를 제공하는 부문
신규 약물전달 시스템 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Novel drug delivery systems are advanced pharmaceutical technologies aimed at improving the effectiveness, safety, bioavailability, and targeted delivery of medications by precisely controlling the rate, timing, and location of drug release in the body. These systems address the shortcomings of traditional delivery methods, enhance treatment outcomes, and boost patient adherence across diverse medical and therapeutic fields.
Key formulation types within novel drug delivery systems include liposomes, nanoparticles, microspheres, hydrogels, and dendrimers. Liposomes are spherical vesicles made of phospholipid bilayers that encapsulate drugs, allowing for targeted delivery, controlled release, and minimized drug toxicity. The delivery modes include targeted, controlled, and modulated drug delivery systems, which are administered through various routes such as oral, injectable, pulmonary, transdermal, and others. These systems are applied in multiple therapeutic areas including cancer, cardiovascular diseases, neurological disorders, infectious diseases, and autoimmune diseases, serving end-users like hospitals, specialty clinics, research centers, and more.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The novel drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides novel drug delivery systems market statistics, including novel drug delivery systems industry global market size, regional shares, competitors with a novel drug delivery systems market share, detailed novel drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the novel drug delivery systems industry. This novel drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The novel drug delivery systems market size has grown rapidly in recent years. It will grow from $106.95 billion in 2024 to $117.66 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth during the historic period can be linked to the increasing prevalence of chronic diseases, an expanding geriatric population, rising demand for minimally invasive treatments, heightened patient awareness about drug efficacy and safety, and the development of global healthcare infrastructure.
The novel drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $171.02 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth projected for the forecast period can be attributed to a heightened global emphasis on pandemic preparedness, increased demand for rapid and targeted drug delivery, greater awareness of antimicrobial stewardship, stricter environmental and packaging regulations favoring controlled delivery methods, and expanding public-private partnerships in pharmaceutical innovation. Key trends during this period include the incorporation of nanocarriers and nanoemulsions, development of biodegradable and stimuli-responsive materials, wider use of 3D printing for personalized dosage forms, advancements in transdermal and microneedle technologies, and the adoption of artificial intelligence in formulation design.
The increasing cases of neurological disorders are anticipated to drive growth in the novel drug delivery systems market. Neurological disorders like stroke involve the sudden loss of neurological function caused by interrupted blood flow to the brain, either through a blockage (ischemic stroke) or a blood vessel rupture (hemorrhagic stroke), resulting in brain damage and possible long-term impairments in cognition, sensation, or movement. Factors such as aging populations, the rising prevalence of lifestyle-related conditions including hypertension, diabetes, and obesity, as well as greater exposure to chronic stress and environmental risks, are contributing to the increase in neurological disorders. Novel drug delivery systems aid in treating these disorders by providing targeted and controlled delivery of medications across the blood-brain barrier. For example, in November 2024, the National Health Service (NHS) England reported that stroke admissions in England reached 111,137 in 2023/24, with the highest rise seen in the 50-59 age group, which had 12,533 new cases. Consequently, the growing incidence of neurological disorders is fueling the novel drug delivery systems market.
Leading companies in the novel drug delivery systems market are innovating with products like oral thin films to improve patient compliance and treatment effectiveness. Oral thin films are rapidly dissolving strips applied inside the mouth that deliver drugs directly into the bloodstream through the mucosal lining. For example, in February 2024, CD Formulation, a US pharmaceutical formulation company, introduced Oral Thin Film Technology. This technology enables quick drug absorption by bypassing the gastrointestinal tract and liver metabolism, making it ideal for patients who have difficulty swallowing. It also allows precise dosing and faster onset of effects, enhancing treatment accuracy and convenience across multiple therapies.
In April 2023, DifGen Pharmaceuticals LLC, a US-based pharmaceutical firm, acquired Aveva Drug Delivery Services Inc. for an undisclosed sum. This acquisition is intended to expand DifGen's expertise in complex dosage forms by adding US research and manufacturing capabilities for transdermal and thin film drug delivery systems. Aveva Drug Delivery Services Inc. specializes in transdermal drug delivery and oral dissolvable films.
Major players in the novel drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Thermo Fisher Scientific Company, AstraZeneca PLC, Abbott Laboratories, Novartis AG, GlaxoSmithKline PLC (GSK), Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences, Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Regeneron Pharmaceuticals, Samyang Holdings Corporation, and Galen Limited.
North America was the largest region in the novel drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in novel drug delivery systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the novel drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The novel drug delivery systems market consists of sales of implants, micelles, exosomes, prodrugs, nasal drug delivery devices, buccal drug delivery films, and ocular drug delivery inserts. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Novel Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on novel drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for novel drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The novel drug delivery systems market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Formulation Type: Liposomes; Nanoparticles; Microspheres; Hydrogels; Dendrimers
2) By Mode Of Novel Drug Delivery System (NDDS): Targeted Drug Delivery Systems; Controlled Drug Delivery Systems; Modulated Drug Delivery Systems
3) By Route: Oral Drug Delivery Systems; Injectable Drug Delivery Systems; Pulmonary Drug Delivery Systems; Transdermal Drug Delivery Systems; Other Routes
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Novel Drug Delivery Systems Market Characteristics
3. Novel Drug Delivery Systems Market Trends And Strategies
4. Novel Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Novel Drug Delivery Systems Growth Analysis And Strategic Analysis Framework
5.1. Global Novel Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Novel Drug Delivery Systems Market Growth Rate Analysis
5.4. Global Novel Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Novel Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Novel Drug Delivery Systems Total Addressable Market (TAM)
6. Novel Drug Delivery Systems Market Segmentation
6.1. Global Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Liposomes
Nanoparticles
Microspheres
Hydrogels
Dendrimers
6.2. Global Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Targeted Drug Delivery Systems
Controlled Drug Delivery Systems
Modulated Drug Delivery Systems
6.3. Global Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Drug Delivery Systems
Injectable Drug Delivery Systems
Pulmonary Drug Delivery Systems
Transdermal Drug Delivery Systems
Other Routes
6.4. Global Novel Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer
Cardiovascular Diseases
Neurological Disorders
Infectious Diseases
Autoimmune Diseases
6.5. Global Novel Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Specialty Clinics
Research Centers
Other End-Users
6.6. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Liposomes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
PEGylated Liposomes
Cationic Liposomes
Stealth Liposomes
Immunoliposomes
6.7. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymeric Nanoparticles
Lipid Nanoparticles
Metallic Nanoparticles
Nanocrystals
6.8. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Microspheres, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biodegradable Microspheres
Magnetic Microspheres
Radioactive Microspheres
Mucoadhesive Microspheres
6.9. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Hydrogels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Thermosensitive Hydrogels
Ph-Responsive Hydrogels
Injectable Hydrogels
Smart Hydrogels
6.10. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Dendrimers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
PAMAM Dendrimers
PPI Dendrimers
Pegylated Dendrimers
Hybrid Dendrimers
7. Novel Drug Delivery Systems Market Regional And Country Analysis
7.1. Global Novel Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Novel Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Novel Drug Delivery Systems Market
8.1. Asia-Pacific Novel Drug Delivery Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Novel Drug Delivery Systems Market
9.1. China Novel Drug Delivery Systems Market Overview
9.2. China Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Novel Drug Delivery Systems Market
10.1. India Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Novel Drug Delivery Systems Market
11.1. Japan Novel Drug Delivery Systems Market Overview
11.2. Japan Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Novel Drug Delivery Systems Market
12.1. Australia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Novel Drug Delivery Systems Market
13.1. Indonesia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Novel Drug Delivery Systems Market
14.1. South Korea Novel Drug Delivery Systems Market Overview
14.2. South Korea Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Novel Drug Delivery Systems Market
15.1. Western Europe Novel Drug Delivery Systems Market Overview
15.2. Western Europe Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Novel Drug Delivery Systems Market
16.1. UK Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Novel Drug Delivery Systems Market
17.1. Germany Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Novel Drug Delivery Systems Market
18.1. France Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Novel Drug Delivery Systems Market
19.1. Italy Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Novel Drug Delivery Systems Market
20.1. Spain Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Novel Drug Delivery Systems Market
21.1. Eastern Europe Novel Drug Delivery Systems Market Overview
21.2. Eastern Europe Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Novel Drug Delivery Systems Market
22.1. Russia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Novel Drug Delivery Systems Market
23.1. North America Novel Drug Delivery Systems Market Overview
23.2. North America Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Novel Drug Delivery Systems Market
24.1. USA Novel Drug Delivery Systems Market Overview
24.2. USA Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Novel Drug Delivery Systems Market
25.1. Canada Novel Drug Delivery Systems Market Overview
25.2. Canada Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Novel Drug Delivery Systems Market
26.1. South America Novel Drug Delivery Systems Market Overview
26.2. South America Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Novel Drug Delivery Systems Market
27.1. Brazil Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Novel Drug Delivery Systems Market
28.1. Middle East Novel Drug Delivery Systems Market Overview
28.2. Middle East Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Novel Drug Delivery Systems Market
29.1. Africa Novel Drug Delivery Systems Market Overview
29.2. Africa Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Novel Drug Delivery Systems Market Competitive Landscape And Company Profiles
30.1. Novel Drug Delivery Systems Market Competitive Landscape
30.2. Novel Drug Delivery Systems Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Novel Drug Delivery Systems Market Other Major And Innovative Companies
31.1. Bayer AG
31.2. Sanofi SA
31.3. Bristol-Myers Squibb Company
31.4. Thermo Fisher Scientific Company
31.5. AstraZeneca PLC
31.6. Abbott Laboratories
31.7. Novartis AG
31.8. GlaxoSmithKline PLC (GSK)
31.9. Takeda Pharmaceutical Company Limited
31.10. Eli Lilly and Company
31.11. Gilead Sciences
31.12. Amgen Inc.
31.13. Teva Pharmaceutical Industries Ltd.
31.14. Otsuka Pharmaceutical Co. Ltd.
31.15. Boston Scientific Corporation
32. Global Novel Drug Delivery Systems Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Novel Drug Delivery Systems Market
34. Recent Developments In The Novel Drug Delivery Systems Market
35. Novel Drug Delivery Systems Market High Potential Countries, Segments and Strategies
35.1 Novel Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
35.2 Novel Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
35.3 Novel Drug Delivery Systems Market In 2029 - Growth Strategies
